1 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.64% |
2 | CRSP | CRISPR Therapeutics AG | 5.59% |
3 | RNA | Avidity Biosciences, Inc. | 4.76% |
4 | GH | Guardant Health, Inc. | 4.71% |
5 | ILMN | Illumina, Inc. | 4.32% |
6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.23% |
7 | NTRA | Natera, Inc. | 3.94% |
8 | QGEN | Qiagen N.V. | 3.71% |
9 | TECH | Bio-Techne Corporation | 3.60% |
10 | LEGN | Legend Biotech Corporation | 3.42% |
11 | MRNA | Moderna, Inc. | 3.31% |
12 | WGS | GeneDx Holdings Corp. | 3.29% |
13 | BNTX | BioNTech SE | 3.05% |
14 | QURE | uniQure N.V. | 3.05% |
15 | BMRN | BioMarin Pharmaceutical Inc. | 3.03% |
16 | VCYT | Veracyte, Inc. | 2.95% |
17 | VRTX | Vertex Pharmaceuticals Incorporated | 2.77% |
18 | RARE | Ultragenyx Pharmaceutical Inc. | 2.66% |
19 | HKG: 1548 | Genscript Biotech Corporation | 2.66% |
20 | BEAM | Beam Therapeutics Inc. | 2.32% |
21 | A | Agilent Technologies, Inc. | 2.07% |
22 | LON: AZN | AstraZeneca PLC | 1.90% |
23 | NTLA | Intellia Therapeutics, Inc. | 1.89% |
24 | GILD | Gilead Sciences, Inc. | 1.86% |
25 | TWST | Twist Bioscience Corporation | 1.76% |
View GNOM holdings |